通过IL-18介导的瘤免疫逃避
Shuai Li1, Chenxia Gao1, Hongyu Zhao1
1School of Basic Medicine, Jiamusi University, Jiamusi 154007, China.
Current issues in molecular biology
|February 27, 2026
概括
介素-18 (IL-18) 在癌症免疫逃避中起着双重作用,受瘤微环境的影响. 了解IL-18的使用方法
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 癌症的免疫逃避是由免疫抑制性瘤微环境 (TME) 驱动的.
- 介乐-18 (IL-18) 是一种调节免疫反应的关键细胞因子,由IL-18结合蛋白 (IL-18BP) 反抗.
- 在瘤中IL-18的功能取决于情境,根据癌症类型,阶段和TME信号传递而有所不同.
研究的目的:
- 审查IL-18在瘤免疫逃避中的机制.
- 分析IL-18在癌症中的上下文依赖性影响和异质性.
- 确定临床翻译挑战,并提出基于IL-18的精确治疗策略.
主要方法:
- 系统审查IL-18在瘤免疫逃避中的作用模式.
- 对IL-18核心调节机制和信号通路的分析.
- 评估异质性模式和临床翻译障碍.
主要成果:
- IL-18在瘤进展中表现出上下文依赖的免疫调节作用.
- TME显著影响IL-18的功能和对免疫规避的影响.
- 在IL-18效应的异质性给临床应用带来了挑战.
结论:
- IL-18在免疫逃避中的复杂作用需要对有效的癌症治疗有更深入的了解.
- 准IL-18通路为新的精确癌症治疗提供了潜力.
- 克服临床翻译障碍对于利用IL-18在癌症管理中至关重要.
更多相关视频
10:13Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
Published on: May 6, 2019
9.6K
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
1.9K
相关概念视频
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
The Tumor Microenvironment
8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
T Cell Types and Functions
2.9K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.9K
Cytotoxic T Cells-mediated Immune Response
7.7K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.7K
